Gemcitabine Impurity 27 | CAS 861445-88-7 - Request Quote
Gemcitabine Impurity 27
| SZ CAT No: | SZ-G007045 |
| CAS No | 861445-88-7 |
| Mol.F. | C5H8F2O4 |
| Mol.Wt. | 170.1 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Gemcitabine Impurity 27 is chemically (4R,5R)-3,3-Difluoro-5-(hydroxymethyl)tetrahydrofuran-2,4-diol. Gemcitabine Impurity 27 is supplied with detailed characterization data compliant with regulatory guideline. Gemcitabine Impurity 27 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Gemcitabine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 861445-88-7
Purchase 861445-88-7
Order 861445-88-7
Enquire 861445-88-7
price of 861445-88-7
861445-88-7 Supplier
861445-88-7 Manufacturer
861445-88-7 Exporter
buy high quality Gemcitabine Impurity 27
Purchase Gemcitabine Impurity 27
Gemcitabine Impurity 27 suppliers
Gemcitabine Impurity 27 manufacturers
Gemcitabine Impurity 27 price
Order Gemcitabine Impurity 27
Enquire Gemcitabine Impurity 27
Gemcitabine Impurity 27 cost
Gemcitabine Impurity 27 Supplier
Gemcitabine Impurity 27 Distributor
Gemcitabine Impurity 27 for Method Validation
Gemcitabine Reference Standard
Gemcitabine Impurity 27 for ANDA Filing
Gemcitabine Impurity 27 for Forced Degradation Studies
Gemcitabine Impurity 27 Identification Standards
Gemcitabine Impurity 27 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.